US Stock MarketDetailed Quotes

IPA ImmunoPrecise Antibodies

Watchlist
  • 0.517
  • +0.057+12.35%
Close Jan 15 16:00 ET
  • 0.500
  • -0.017-3.25%
Post 18:16 ET
16.05MMarket Cap-0.69P/E (TTM)

ImmunoPrecise Antibodies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ImmunoPrecise Antibodies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 6.770M--
--2025/Q3-- / 6.585M--
Dec 10, 20242025/Q26.125M / 6.439M--
Sep 16, 20242025/Q15.263M / 6.750M--
Jul 29, 20242024/Q46.459M / 6.530M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 6.770M--
--2025/Q3-- / 6.585M--
Dec 10, 20242025/Q26.125M / 6.439M--
Sep 16, 20242025/Q15.263M / 6.750M--
Jul 29, 20242024/Q46.459M / 6.530M--

Unlock Free Earnings Estimates

ImmunoPrecise Antibodies Earnings Reports

  • ImmunoPrecise Antibodies | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

    Dec 10, 2024 21:39

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 10, 2024 21:39

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 10, 2024 21:35

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 3, 2024 21:36

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 15, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data